Histidine-rich glycoprotein (HRGP), a plasma protein with anti-heparin and anti-fibrinolytic activity, has been associated with thrombophilia in three families. Therefore, it may promote hyper-coagulability. The following objectives have been achieved in the laboratory: purification of HRGP, using a combination of cobalt-sepharose, and development of an enzyme-linked immunosorbent assay for its quantitation. We have confirmed HRGP's anti-heparin activity and demonstrated that it binds to plasminogen. An ongoing project is the study of HRGP binding to proteins that contain a """"""""kringle"""""""" structure. By identifying binding sites for HRGP, we hope to discover potential functions for this protein.

Agency
National Institute of Health (NIH)
Institute
Clinical Center (CLC)
Type
Intramural Research (Z01)
Project #
1Z01CL010220-05
Application #
6161525
Study Section
Cognition and Perception Study Section (CP)
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Clinical Center
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Horne 3rd, M K; Merryman, P K; Cullinane, A M (2001) Histidine-proline-rich glycoprotein binding to platelets mediated by transition metals. Thromb Haemost 85:890-5